Badgley, Phelps & Bell’s Array Biopharma Inc ARRY Stock Holding History

Badgley, Phelps & Bell’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-34,500	Closed	-$1.6M	–	201
2019 Q2	$1.6M	Hold	34,500	–	–	0.09%	110
2019 Q1	$841K	Hold	34,500	–	–	0.05%	124
2018 Q4	$492K	Hold	34,500	–	–	0.04%	136
2018 Q3	$524K	Hold	34,500	–	–	0.03%	137
2018 Q2	$579K	Hold	34,500	–	–	0.04%	134
2018 Q1	$563K	Sell	34,500 -3,000	-8%	-$48.1K	0.04%	133
2017 Q4	$480K	Buy	+37,500	New	+$427K	0.03%	145

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Badgley, Phelps & Bell's ARRY Position: Q3 2019 in Review

Badgley, Phelps & Bell sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 34,500 shares — an estimated $1.6M sold.

Badgley, Phelps & Bell first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $1.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Badgley, Phelps & Bell reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Badgley, Phelps & Bell sold 34,500 Array Biopharma Inc shares in Q3 2019, an estimated $1.6M.
Badgley, Phelps & Bell first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
Badgley, Phelps & Bell's Array Biopharma Inc position peaked at $1.6M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Badgley, Phelps & Bell's 13F filing for Q3 2019, filed 4 Nov 2019.